海外の治験の状況「COVID-19」での検索結果
210件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
- Pancreatic Cancer;Pancreatic Cancer;Pancreatic Cancer;Pancreatic Cancer
- United States
- 2014-01-15
Not Recruiting
- The effect of Nandrolone Decanoate Injection and Leucine Supplementation on Muscle Loss During Immobilisation
- muscle atrophy
- The Netherlands
- 2015-07-02
Not Recruiting
- Effect of breastfeeding mothers by trained volunteers mothers to the initiation and continuation of breastfeeding in district 19 of Tehran
- Breastfeeding continuation in breastfeed mothers.
- Iran (Islamic Republic of)
- 2015-05-16
Not recruiting
- Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland
- Dementia;Caregiver Burden;Dementia;Caregiver Burden
- United States
- 2015-03-10
Not recruiting
- The Effect of Nandrolone Decanoate and Leucine on Muscle Loss
- Muscle Atrophy;Muscle Atrophy;Muscle Atrophy;Muscle Atrophy
- Netherlands
- 2015-02-19
Not recruiting
- Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
- Pulmonary Disease, Chronic Obstructive
- 2012-06-07
Not recruiting
- Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
- Cachexia; Cancer
- Brazil
- 2017-08-15
Not recruiting
- Feasibility of an Individual Placement and Support (IPS) prototype for young people aged 18-19 with mild and moderate mental health conditions developed by the Community Mental Health Service at Odyssey House in Christchurch, "Taking Charge",
- mental health
- New Zealand
- 2018-03-09
Not Recruiting
- Studies on the gastrointestinal hormone fibroblast growth factor 19 (FGF19) in overweight and obese patients with non-alcoholic fatty liver diseases (NAFLD)
- ;K76.0 - Fatty (change of) liver, not elsewhere classified;E66.0 - Obesity due to excess calories
- Germany
- 2018-01-30
Not recruiting
- Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations
- Thoracic Neoplasms;Thoracic Neoplasms;Thoracic Neoplasms;Thoracic Neoplasms
- China
- 2009-12-01